跳至主導覽
跳至搜尋
跳過主要內容
臺北醫學大學 首頁
說明與常見問題
English
中文
首頁
專家檔案
研究單位
專案
研究成果
資料集
活動
按專業知識、姓名或所屬機構搜尋
查看斯高帕斯 (Scopus) 概要
許 金旺
副教授
,
急診學科
主治醫師
,
臺北市立萬芳醫院
https://orcid.org/0000-0003-4973-1050
電子郵件
Wan11119
gmail
com
h-index
2489
引文
28
h-指數
按照存儲在普爾（Pure）的出版物數量及斯高帕斯（Scopus）引文計算。
1999 …
2025
每年研究成果
概覽
指紋
網路
專案
(2)
研究成果
(145)
資料集
(1)
類似的個人檔案
(6)
指紋
查看啟用 Chin-Wang Hsu 的研究主題。這些主題標籤來自此人的作品。共同形成了獨特的指紋。
排序方式
重量
按字母排序
Pharmacology, Toxicology and Pharmaceutical Science
Acute Lung Injury
74%
Ischemia
68%
Diabetes Mellitus
57%
Cohort Study
56%
Injury
42%
Adverse Outcome
42%
Community Acquired Pneumonia
41%
Baicalein
41%
Nitric Oxide
39%
Imipenem
35%
Hyperglycemia
34%
Acute Heart Infarction
34%
Oxidizing Agent
33%
Hemoglobin A1c
31%
Antiinfective Agent
31%
Sphingosine 1 Phosphate
30%
Bacteremia
30%
Randomized Controlled Trial
30%
Observational Study
30%
Penicillinase
29%
Chronic Obstructive Lung Disease
26%
Placebo
26%
Reperfusion Injury
25%
Infection
24%
Biological Marker
23%
Acinetobacter Baumannii
22%
Carbapenem
22%
Tigecycline
22%
Ventilator Associated Pneumonia
20%
Proanthocyanidin
20%
Hypokalemic Periodic Paralysis
20%
Brain Ischemia
20%
Asthma
20%
Paralysis
20%
Sulbactam
20%
Antimicrobial Resistance
20%
Grape
20%
Pyogenic Liver Abscess
20%
Extended Spectrum Beta Lactamase
20%
Baicalin
20%
Lidocaine
20%
Migraine
20%
Air Embolism
20%
Hypoglycemia
20%
Marfan Syndrome
20%
Glutamine
20%
Anura
20%
Comorbidity
18%
Minimum Inhibitory Concentration
18%
Enterobacteriaceae
17%
Medicine and Dentistry
Emergency Department
100%
Meta-Analysis
95%
Systematic Review
84%
Diabetes Mellitus
51%
Glycemic
47%
Cohort Analysis
41%
Adverse Outcome
39%
Infection
31%
Intensive Care Unit
30%
Hemoglobin A1c
30%
Diagnosis
29%
Injury
28%
Penicillinase
26%
Early Diagnosis
25%
Aortic Dissection
25%
Acute Heart Infarction
25%
Hyperglycemia
24%
Thorax Pain
24%
Carbapenem
22%
Surgery
22%
Disease
22%
Pediatrics
22%
Spinal Anaesthesia
21%
Odds Ratio
21%
Femur Fracture
20%
Diagnostic Performance
20%
Marfan Syndrome
20%
Anatomy
20%
Inflammatory Bowel Disease
20%
Pyogenic Liver Abscess
20%
Resuscitation
20%
Extended Spectrum Beta Lactamase
20%
Antibiotic Resistance
20%
Symptom
18%
Anodyne
17%
Enterobacteriaceae
17%
Escherichia coli
17%
Clinician
16%
Computer Assisted Tomography
16%
Enterobacter Cloacae
15%
Observational Study
15%
Echography
14%
Randomized Controlled Trial
14%
Imipenem
14%
Combination Therapy
13%
Carbapenem Derivative
13%
Hazard Ratio
13%
Klebsiella pneumoniae
13%
Major Adverse Cardiac Event
13%
Placebo
13%
Nursing and Health Professions
Meta Analysis
82%
Systematic Review
53%
Emergency Ward
38%
Hemoglobin A1c
34%
Hyperglycemia
34%
Confidence Interval
33%
Adverse Outcome
31%
Intensive Care Unit
30%
Diabetes Mellitus
29%
Glucose Level
27%
Patient with Diabetes
23%
Analgesic Agent
23%
Acute Heart Infarction
22%
Cohort Analysis
21%
Diagnosis
21%
Femur Fracture
20%
Carbapenem
20%
Pyogenic Liver Abscess
20%
Resuscitation
20%
Spinal Anaesthesia
20%
Hypoglycemia
20%
Brain Ischemia
20%
Odds Ratio
15%
Major Adverse Cardiac Event
14%
Glycosylated Hemoglobin
13%
Postoperative Pain
13%
Tranexamic Acid
12%
Hemoglobin Blood Level
12%
Infusion
12%
Glucose Blood Level
11%
Receiver Operating Characteristic
11%
Critical Illness
11%
Placebo
11%
Strabismus Surgery
11%
Obstructive Lung Disease
10%
Kidney Colic
10%
Out of Hospital Cardiac Arrest
10%
Colorectal Cancer
10%
Extended Spectrum Beta Lactamase
10%
Scaphoid Fracture
10%
Treatment Outcome
10%
Percutaneous Catheter
10%
Cone Beam Computed Tomography
10%
Air Embolism
10%
Dexmedetomidine
10%
Hemoptysis
10%
Appendectomy
10%
Magnesium Sulfate
10%
Acute Care Setting
10%
Nerve Block
10%
